Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

When will yervoy's patent expire?

See the DrugPatentWatch profile for yervoy

Yervoy (ipilimumab) is a brand-name biologic (an antibody), so its “patent life” depends on which specific patent(s) and exclusivities you mean (US vs. Europe, primary composition vs. formulation vs. method-of-use, etc.).

In the United States, the principal biologic exclusivity for Yervoy began after FDA approval in 2011, and the earliest expected expiration of exclusivity is generally cited as 2021. However, actual market exclusivity/patent protection can extend beyond that due to additional, separate patents and follow-on exclusivities (and biosimilar approval pathways).

If you tell me which country (US/Europe/etc.) and whether you mean patent expiration vs. biologic exclusivity vs. biosimilar launch eligibility, I can give you a more precise answer.



Other Questions About Yervoy :

What are the symptoms of yervoy overdose? Is yervoy assistance income based? Can yervoy s severe side effects be life threatening? Are yervoy discounts valid for previous yervoy treatments? How long does yervoy s discount last? Can you provide more information on the yervoy discount terms? How much does yervoy cost with insurance?

AI-Drug Label Prescribing Information Alignment Report

Drug Brand Mention Assessment

Branding Score
5
Visibility
10
Mentioned
Ranking
#1
Sentiment
50
Recommendation Status
mentioned only
Brand Perception
Best Known For


Core Claims
  • The information provided does not include Yervoy’s specific patent expiry dates.
Differentiators

Pricing Perception: Not Mentioned